江苏育瑞康生物科技有限公司 Reviews, Salaries and Jobs

Company Overview

Nature: 民营公司 Size: 少于50人 Founded: 11年
Industry: 制药/生物工程、专业服务(咨询、人力资源、财会)
Full name: 江苏育瑞康生物科技有限公司。

Development Stage

Ranking: Ranked #47 in 南京产学研公司 by popularity Ranked #58 in 南京生命科学公司 by popularity Ranked #86 in 南京健康科技公司 by popularity Ranked #103 in 南京预防保健公司 by popularity
Honors: 院士工作站高新技术企业 According to algorithm
Salary: 82.6% of positions earn 8-15K, In 2026 vs last yeardecreased by 8%.。.
Recruiting: In 2026 vs 2025decreased by 73%.
Requirement: Education: 大专 leads with 78.3%. Experience: 3-5年 leads with 69.6%.
Region: Distributed across 1 regions, 南京: 100%.

About the Company

育瑞康生物科技有限公司是由中国工程院陆道培院士技术领衔的，陆道培医疗集团旗下致力于细胞生物学的基础研究和临床转化技术研究的高新技术企业。通过在干细胞技术、免疫细胞技术、基因工程等领域的研发与创新，给患者和亚健康人群提供先进的精准医学技术服务和健康管理，为提升人类的生命质量而努力！ 2018年1月18日江苏育瑞康生物科技有限公司成功入选2017年度南京市“科技顶尖专家集聚计划”，项目名称为“应用于GVHD治疗的人间充质干细胞开发及产业化”。在二十个重点项目中排名第六。江苏育瑞康的细胞临床转化科创中心暨陆道培院士工作站，落户在南京明基医院，实验室共计2000多平方，包括干细胞实验室、免疫细胞实验室、外泌体实验室、PCR实验室，以及综合细胞库，拟建成中国*个通过国际细胞治疗标准FACT认证的临床转化实验室。努力成为国际先进的生物治疗技术创新交流与落地转化平台，亚洲细胞生物学*高技术水准的研发中心。

Expand

Information is aggregated from the web and may not be exact. For reference only.

Information incorrect? Claim this company to edit

How Fast Is Hiring Growing?

Manage

Growth Rate

2026 vs 2025

2025: Up 45%
2024: Up 107%
2023: Up 200%

Year-by-Year Hiring:

2022 5 jobs 2023 15 jobs 2024 31 jobs 2025 45 jobs 2026 ? *** 

* Hiring was generally low during 2020-2022 due to the pandemic

Latest Jobs

研发管理

南京 | 本科以上 | 5-10年 | 全职 | 8000-12000元

2026-06-17

Note: How fast is hiring at 江苏育瑞康生物科技有限公司 growing? 2025: 45 openings (up 45%), 2024: 31 openings (up 107%), 2023: 15 openings (up 200%), 2022: 5 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Doctoral Degree Job Demand Analysis

(More)

N/A

Growth Rate

Doctoral Hiring by Year: 2024 — same as 2023

2022 1 jobs 2023 1 jobs 2024 1 jobs

* Hiring was generally low during 2020-2022 due to the pandemic

N/A

Doctoral Salary 򀀩

How fast is doctoral hiring at 江苏育瑞康生物科技有限公司 growing? Doctorate recruitment over the years: 2024: 1 openings (up 107%), 2023: 1 openings (up 200%), 2022: 1 openings.

— What Are the Salaries Like? (23 records)

Manage

Salary Overview

￥8-15K

82.6% of roles pay

salary range: 6K - 50K, 82.6% of roles pay ￥8-15K

8.7% 6-8K ***  ? 8-10K ***  ? 10-15K 4.3% 20-30K 4.3% 50K以上

Note: salary statistics are based on 23 salary records from the past year and depend on the job sample. For reference only.

Salary Ranking

By Category

销售类￥10.4K  市场/公关/媒介类  客户服务类  计算机/网络/技术类  其他（研发和技术类） 

How is the salary at 江苏育瑞康生物科技有限公司?82.6% of positions earn 8-15K, Undergraduate salary: ¥。销售类 average salary ¥10.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)

Are salaries high at 江苏育瑞康生物科技有限公司? We provide: 大客户，销售，区域经理，拓展，新媒体，渠道，运营，客户经理，临床，健康顾问，医学总监，库管，研发助理，研发管理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

销售类
65.2% of total 65.2%
市场/公关/媒介类
26.1% of total 26.1%
客户服务类
17.4% of total 17.4%
计算机/网络/技术类
13% of total 13%

Job Location

南京
100% of total 100%

Education

大专
78.3% of total 78.3%
本科
13% of total 13%
不限
8.7% of total 8.7%

Experience

3-5年
69.6% of total 69.6%
1-3年
17.4% of total 17.4%
5-10年
8.7% of total 8.7%
不限
4.3% of total 4.3%

View Detailed Analysis

What does 江苏育瑞康生物科技有限公司 require? Who is 江苏育瑞康生物科技有限公司 hiring? recruitment: 销售类占比最多占65.2%，其次是市场/公关/媒介类占26.1%. What education can get in at ? 大专占比最多占78.3%，其次是本科占13%. Work experience required at ? 3-5年占比最多占69.6%，其次是1-3年占17.4%. Where are the job locations at ? 南京占比最多占100%. Based on job postings from the past year, for reference only.